Portage Biotech Files 6-K, Confirms Foreign Private Issuer Status
Ticker: ATON · Form: 6-K · Filed: Feb 28, 2024 · CIK: 1095435
| Field | Detail |
|---|---|
| Company | Portage Biotech INC. (ATON) |
| Form Type | 6-K |
| Filed Date | Feb 28, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-filing, foreign-issuer
TL;DR
**Portage Biotech just filed a standard 6-K, confirming its foreign private issuer status and BVI address.**
AI Summary
Portage Biotech Inc. filed a Form 6-K with the SEC on February 28, 2024, for the month of February 2024, indicating its status as a foreign private issuer. The filing confirms the company's business address as Clarence Thomas Building, P.O. Box 4649, Road Town, Tortola, British Virgin Islands, VG1110. This report, with Commission File Number 001-40086, will be incorporated by reference into future filings.
Why It Matters
This routine filing confirms Portage Biotech's compliance with SEC reporting requirements as a foreign private issuer, providing transparency to investors regarding its operational status and location.
Risk Assessment
Risk Level: low — This is a routine administrative filing and does not indicate any specific financial or operational risks.
Key Players & Entities
- Portage Biotech Inc. (company) — registrant
- Clarence Thomas Building (company) — business address
- P.O. Box 4649, Road Town, Tortola, British Virgin Islands, VG1110 (company) — business address
- February 2024 (date) — reporting period
- 001-40086 (company) — Commission File Number
FAQ
What type of report did Portage Biotech Inc. file?
Portage Biotech Inc. filed a Form 6-K, which is a report of a foreign private issuer.
When was this 6-K report filed?
The 6-K report was filed on February 28, 2024, for the month of February 2024.
What is the Commission File Number for Portage Biotech Inc.?
The Commission File Number for Portage Biotech Inc. is 001-40086.
Where are the principal executive offices of Portage Biotech Inc. located?
The principal executive offices of Portage Biotech Inc. are located at Clarence Thomas Building, P.O. Box 4649, Road Town, Tortola, British Virgin Islands, VG1110.
Will this 6-K report be incorporated by reference?
Yes, the report on Form 6-K (including exhibits) shall be deemed to be incorporated by reference into future filings.
Filing Stats: 325 words · 1 min read · ~1 pages · Grade level 10.4 · Accepted 2024-02-28 17:17:22
Filing Documents
- f6k_022824.htm (6-K) — 14KB
- exh_991.htm (EX-99.1) — 1205KB
- exh_992.htm (EX-99.2) — 323KB
- mda_6a.jpg (GRAPHIC) — 35KB
- mda_6b.jpg (GRAPHIC) — 50KB
- mda_11.jpg (GRAPHIC) — 318KB
- 0001171843-24-001050.txt ( ) — 7955KB
- ptgef-20231231.xsd (EX-101.SCH) — 116KB
- ptgef-20231231_cal.xml (EX-101.CAL) — 74KB
- ptgef-20231231_def.xml (EX-101.DEF) — 264KB
- ptgef-20231231_lab.xml (EX-101.LAB) — 431KB
- ptgef-20231231_pre.xml (EX-101.PRE) — 411KB
- f6k_022824_htm.xml (XML) — 1253KB
Management's Discussion and Analysis for the three and nine months ended December 31, 2023
Management's Discussion and Analysis for the three and nine months ended December 31, 2023. 101.INS Inline XBRL Instance Document 101.SCH Inline XBRL Taxonomy Extension Schema Document 101.CAL Inline XBRL Taxonomy Extension Calculation Linkbase Document 101.DEF Inline XBRL Taxonomy Definition Linkbase Document 101.LAB Inline XBRL Taxonomy Extension Label Linkbase Document 101.PRE Inline XBRL Taxonomy Extension Presentation Linkbase Document 104 Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Date: February 28, 2024 PORTAGE BIOTECH INC. By: /s/ Allan Shaw Allan Shaw Chief Financial Officer